Clinical Trial Update: The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS (TETHYS Trial) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating methotrexate therapy in ST-segment elevation myocardial infarction (STEMI). The status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Instituto de Cardiologia do Rio Grande do Sul | Conditions: Myocardial Infarction | Phase 2 | Status: UNKNOWN